Older adults in Latin America are at an increased risk of hospitalisation, ill health, catastrophic disability and death due to vaccine-preventable diseases such as influenza, herpes zoster, and pneumonia. The Latin American Adult Immunisation Advocacy Summit, held in Mexico City, gathered 40 experts in health, ageing and immunisation from 12 Latin American countries to explore good practices of adult vaccination, key country and regional barriers, and strategies to overcome these barriers. The Summit comprised of introductory lectures, plenary panels and breakout sessions with the overarching goal of improving adult vaccination uptake rates throughout the region. Several key messages and recommendations arose from the Summit. Delegates agreed upon the need for a paradigm shift in thinking towards a life course perspective on vaccination to sustain good health throughout life and promote well-being, dignity and functional capacity in older age. Delegates revealed the need for national financial commitment to fixed and irrevocable funding for universal vaccination and the urgent requirement for robust scientific, epidemiologic research in Latin American communities on the cost benefits of such coverage. The recommendations were strengthened through a common understanding of the unique multisectoral and multidisciplinary collaborations essential to influence and help shape public policy.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
World Health Organization (2015) World report on ageing and health. World Health Organization
Ramirez JA, Wiemken TL, Peyrani P et al (2017) Adults hospitalized with Pneumonia in the United States: incidence, epidemiology, and mortality. Clin Infect Dis 65:1806–1812
Isturiz RE, Luna CM, Ramirez J (2010) Clinical and economic burden of pneumonia among adults in Latin America. Int J Infect Dis 14:e852–e856
National Vaccine Advisory Committee (2012) A pathway to leadership for adult immunization: recommendations of the National Vaccine Advisory Committee: approved by the National Vaccine Advisory Committee on June 14, 2011. Public Health Rep (Washington, DC: 1974) 127:1
Cheng AC, Holmes M, Irving LB et al (2013) Influenza vaccine effectiveness against hospitalisation with confirmed influenza in the 2010–11 seasons: a test-negative observational study. PLoS One 8:e68760
Dagan R, Klugman KP (2008) Impact of conjugate pneumococcal vaccines on antibiotic resistance. Lancet Infect diseases 8:785–795
Mody L, Sun R, Bradley SF (2006) Assessment of pneumonia in older adults: effect of functional status. J Am Geriatr Soc 54:1062–1067
Gutiérrez Robledo LM (2016) Vaccination status with a life course perspective in Latin America: adults and older adults. Latin American Adult Immunization Advocacy Summit 9 April 2016. Instituto Nacional de Geriatría, Mexico
Burgess M (2003) Guest editorial: immunisation: a public health success. New South Wales public health bulletin 14:1–5
Michel JP, Chidiac C, Grubeck-Loebenstein B et al (2009) Rejuvenation Res 12:127–136. https://doi.org/10.1089/rej.2008.0813
Gutiérrez-Robledo LM, Caro-López E, Guerrero-Almeida MDL et al (2017) Results of the First Mexican Consensus of Vaccination in the Adult. Medical Gazette of Mexico 153:190–204
Flamini V, Galdamez M, Lambert F et al (2018) Growing pains: is Latin american prepared for population aging? International Monetary Fund
US Census Bureau (2013) International Data Base
United Nations (2013) Profiles of Ageing
Iannella HA, Luna CM (2016) Community-acquired pneumonia in Latin America. In: Seminars in respiratory and critical care medicine, vol 37, No. 06. Thieme Medical Publishers, pp 868–875
Pan American Health Organization / World Health Organization (2016) Influenza Vaccine Coverage in countries and territories of the Americas, 2015-2016. Washington, D.C.: PAHO/WHO; 2016. Updated as of 16 May 2016. PAHO/WHO, D.C. Available at http://ais.paho.org/imm/InfluenzaCoverageMap.asp
Thomson A, Robinson K, Vallée-Tourangeau G (2016) The 5As: a practical taxonomy for the determinants of vaccine uptake. Vaccine 34:1018–1024
Robledo L, Garcia L (2015) Vacunación en el adulto mayor: perspectiva de curso de vida documento de postura. Retrieved from https://www.ifa-fiv.org/wp-content/uploads/2016/04/Vacunacion-en-el-Adulto-Mayor-Perspectiva-de-Curso-de-Vida-Book.pdf
Pan American Health Organization [PAHO] (2016). Country Report. https://www.paho.org/hq/index.php?option=com_docman&view=download&category_slug=country-profiles-im-1808&alias=8627-brazil-country-profile-627&Itemid=270&lang=en. Accessed 1 Mar 2019
Vizzotti C. Programa nacional de control de enfermedades inmunoprevenibles. http://www.msal.gob.ar/index.php/ayuda/51-programa-nacional-de-inmunizaciones. Accessed 10 Jan 2016
Ministerio de salud, Subsecretaria de salud pública, División de prevención y control de enfermedades, Departamento de ciclo vital, Programa nacional de salud del adulto mayor. Programa nacional de salud de las personas adultas mayores MINSAL 2014. Gobierno de Chile. http://web.minsal.cl/sites/default/files/files/Borrador%20documento%20Programa%20Nacional%20de%20Personas%20Adultas%20Mayores-%2004-03_14.pdf. Accessed 10 Jan 2016
Cano Gutiérrez C, Reyes-Ortiz C, Borda MG et al (2016) Self-reported vaccination in the elderly: SABE Bogotá study, Colombia. Colombia Médica 47:25–30
Jamotte A, Clay E, Macabeo B et al (2017) Public health impact and economic benefits of quadrivalent influenza vaccine in Latin America. Human Vaccines Immunother 13:877–888
Davis BM, Black D (2017) Identifying the challenges to adult influenza vaccination in Latin America. Value Health 20:A934
Bloom DE, Fan VY, Sevilla JP (2018) The broad socioeconomic benefits of vaccination. Sci Transl Med. https://doi.org/10.1126/scitranslmed.aaj2345
Busby C (2018) Not just for kids: how to improve adult vaccination uptake in Canada
Hsu DJ, North CM, Brode SK, Celli BR (2016) Identification of barriers to influenza vaccination in patients with chronic obstructive pulmonary disease: analysis of the 2012 behavioral risk factors surveillance system. Chronic Obstr Pulm Dis 3:620-627
Tan L (2015) Adult vaccination: now is the time to realize an unfulfilled potential. Hum Vaccines Immunother 11:2158–2166
Dube E, Vivion M, MacDonald NE (2015) Vaccine hesitancy, vaccine refusal and the anti-vaccine movement: influence, impact and implications. Expert Rev Vaccines 14:99–117
Paterson P, Meurice F, Stanberry LR, Glismann S, Rosenthal SL, Larson HJ (2016) Vaccine hesitancy and healthcare providers. Vaccine 34:6700–6706
Suaya JA, Jiang Q, Scott DA et al (2018) Post hoc analysis of the efficacy of the 13-valent pneumococcal conjugate vaccine against vaccine-type community-acquired pneumonia in at-risk older adults. Vaccine 36:1477–1483
Regional Office for the Americas of the World Health Organization (2018) PAHO Revolving Fund. Retrieved from https://www.paho.org/hq/index.php?option=com_content&view=article&id=1864:paho-revolving-fund&Itemid=4135&lang=en
Michel JP, Gusmano M, Blank PR et al (2010) Vaccination and healthy ageing: how to make life-course vaccination a successful public health strategy. Eur Geriatr Med 1:155–165
Giese C, Mereckiene J, Danis K et al (2016) Low vaccination coverage for seasonal influenza and pneumococcal disease among adults at-risk and health care workers in Ireland, 2013: the key role of GPs in recommending vaccination. Vaccine 34:3657–3662
Eilers R, van Lier A, Suijkerbuik A et al (2016) The willingness of older adults to receive vaccination against influenza, pneumococcal disease, herpes zoster and pertussis and the role of the general practitionersRenske Eilers. Eur J Public Health 26(suppl_1)
Levin-Zamir D, Bertschi I (2018) Media health literacy, eHealth literacy, and the role of the social environment in context. Int J Environ Res Public Health 15:1643
Pan American Health Organization (2018) Immunization program. https://www.paho.org/hq/index.php?option=com_content&view=article&id=289:immunization-program&Itemid=384&lang=pt
The IFA would like to thank the Mexican National Institute of Geriatrics and the Mexican National Institute of Public Health for co-hosting this Summit, and the participation of the Mexican National Institute of Geriatrics and delegates for their invaluable contributions. We also thank Dr Maria De Lourdes Garcia–Garcia, Dr Luis Miguel Gutiérrez Robledo and Ms Jessica Rochman-Fowler for their contributions to this article.
Conflict of interest
The Latin American Adult Immunisation Advocacy Summit was funded by an unrestricted educational grant from Pfizer Inc.
The article does not contain studies with human participants or animals performed by the authors, rather it is a reflection of the summit outcomes.
For this type of study formal consent is not required.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Barratt, J., Mishra, V. & Acton, M. Latin American Adult Immunisation Advocacy Summit: Overcoming regional barriers to adult vaccination. Aging Clin Exp Res 31, 339–344 (2019). https://doi.org/10.1007/s40520-019-01156-z
- Adult vaccination
- Public health
- Healthy ageing
- Latin America